Free Trial

NovoCure (NVCR) SEC Filings & 10K Form

NovoCure logo
$17.73 +0.64 (+3.74%)
(As of 11/22/2024 ET)

Recent NovoCure SEC Filings

DateFilerForm TypeView
11/06/2024
3:27 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:00 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:05 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
5:21 PM
NovoCure (Issuer)
Paravasthu Mukund (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:16 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:17 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
7:19 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:20 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:21 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:22 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:24 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:25 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:16 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:17 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
7:18 AM
NovoCure (Filer)
Form S-8 POS
07/25/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
6:05 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
12:14 PM
NovoCure (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
NovoCure (Subject)
Form SC 13G/A
06/06/2024
5:37 PM
NovoCure (Issuer)
Ocean Allyson J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:13 PM
Madden Martin J. (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:55 PM
Hung David (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:42 PM
LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:42 PM
NovoCure (Issuer)
Scannell Timothy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:43 PM
NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:43 PM
NovoCure (Issuer)
Stafford Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:09 PM
HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:01 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/27/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:39 PM
NovoCure (Subject)
Shah Pritesh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:17 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:43 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:35 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

02/22/2024
6:11 AM
NovoCure (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:05 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:06 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:28 AM
FMR LLC (Filed by)
NovoCure (Subject)
Form SC 13G/A
01/18/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:57 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2024
4:15 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:10 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:10 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:23 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
5:19 AM
Capital World Investors (Filed by)
NovoCure (Subject)
Form SC 13G/A
11/28/2023
6:30 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVCR) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners